Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

Brettj, Welcome back. I agree PN is a poor presenter. There was no change in his delivery of this presentation.

Bullet point summary:

Still no IND on the second drug BP1002

No news on enrolled patients in the phase II trial

No new cancer targets for BP1001 in phase I

Still only 4 phase II test sites. The clock is running at $2-2.5 million per month burn rate.

The only good news....10 sites will be up and running for enrollment by April 2017.

I am very disappointed in the presentation. PN must have wanted a company paid vacation as there is no real news here to justify the presentation.

Brettj it is hard to believe PN would not accept help from any source to move our story forward. If he refused help from the Cancer Moonshot he should at a minimum be removed as CEO/CFO and perhaps fired. Certainly this presentation failed to show progress that makes the case for him continuing in his present roles.

Any thoughts from the Board?